エピソード

  • Ep 32 - Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices

    Ep 32 - Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices
    2020/10/23
    In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn -Why Landon left Medtronic -Where Philips fits into medtech’s future -How Philips hopes to expand -Will Philips invest directly in start-ups? -How did Covid-19 impact Philips? We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious? We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker's Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA Subscribe today on your podcast apps!
    続きを読む 一部表示
    37 分
  • Ep 31 - Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?

    Ep 31 - Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?
    2020/10/16
    In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others. Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.
    続きを読む 一部表示
    45 分
  • Ep 30 - Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy

    Ep 30 - Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy
    2020/10/09
    In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages. MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients. Kiil will hit upon Smith + Nephew’s: • CORI Robotics surgical tools • Real Intelligence platform • Interest in Ambulatory Surgery Centers • Balance of OUS vs. US • Future plans for extremities INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on developing a hydrocephalus wearable device that can help this suffering patient population. Somera will discuss • Winning the Global Competition • The power of Rhaeous’ wearable technology • Medtech’s ability to help long suffering patients • The start-up’s fundraising plans. Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.
    続きを読む 一部表示
    54 分
  • Ep 29 - Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity

    Ep 29 - Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity
    2020/10/02

    In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.  Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devicetalks-tuesdays-agenda/

    In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open the the clinical trial market. Also, learn how AliveCor is shifting into more of a service company. Meanwhile, co-cost Chris Newmarker, executive editor of life sciences at MassDevice, is off the the races with his #NewmarkersNewsmakers which includes BD, Boston Scientific, Coloplast, Medtronic and Smith+Nephew.
    続きを読む 一部表示
    37 分
  • Ep 28 - Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges

    Ep 28 - Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges
    2020/09/25
    Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity. In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an industry need to do to bring equality to care. Go to knowyourhealth.com for more information. In our first interview, Jeff Karp, MD, a prolific inventor and entrepreneur, shares his early challenges as a child when a learning difference limited his performance in school. After hearing some stern advice from teachers, Karp identified the problem and explained how overcoming his challenges gave him the ability to see innovative ways to solve problems. Go to devicetalks.com to see the rest of the Device Talks Tuesday interview from Sept. 22. https://www.devicetalks.com/devicetalks-tuesdays-on-demand-sessions/ And, of course, Chris Newmarker, executive editor of MassDevice, runs us through Newmarker’s Newsmakers, the top 5 performing articles on MassDevice. Subjects include Boston Scientific, Farapulse, the FDA, and NanoVibronix. https://www.massdevice.com/the-top-5-massdevice-stories-of-the-week-september-25-2020/ GUESTS:  Camille Chang Gilmore, vice president, human resources and global chief diversity officer, Boston Scientific  Michael Jaff, MD, vice president, CMO, Boston Scientific, peripheral vascular group  Jeff Karp, MD, professor of medicine, Brigham and Women’s Hospital, Harvard Medical School HOSTS  Chris Newmarker, executive editor, life sciences, WTWH Media  Tom Salemi, editorial director, DeviceTalks
    続きを読む 一部表示
    46 分
  • Ep 27 - Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future

    Ep 27 - Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future
    2020/09/19
    INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis. NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is profiled in a 5G documentary called “Speed of Thought.” Check it out on Amazon Prime and other channels. Finally, the week wouldn't be complete with Chris Newmarker, executive editor of MassDevice, revealing this week’s #Newmarkersnewsmakers featuring news from Hologic, Varian, Smith & Nephew, and Outset Medical.
    続きを読む 一部表示
    47 分
  • Ep 26 - Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary

    Ep 26 - Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary
    2020/09/12
    MANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and President MedSurg. After a slow start due to COVID-19 shutdowns, Boston Scientific is putting the pedal to the metal by leveraging its extensive reach and might. Executives from both companies share why they can't see the ceiling to the potential of this technology. MassDevice's Executive Editor Chris Newmarker will reveal this week’s #NewmarkersNewsmakers including Bardy Diagnostics, Kevin Hykes, COVID-19 Vaccine makers, Theranica, Joe Biden, Donald Trump and Theranos founder Elizabeth Holmes.
    続きを読む 一部表示
    54 分
  • Ep 25 - Raising capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?

    Ep 25 - Raising capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?
    2020/09/04
    Our line up in Episode 25 of the DeviceTalks Weekly Podcast INNOVATION & FINANCE – Managing Partner Karen Long says COVID-19 isn’t slowing down KCK Group, which closed on two major investments this summer. Long will be speaking on our first DeviceTalks Tuesday’s “Raising Capital in the Zoom Age.” Go to devicetalks.com. REGULATORY & REIMBURSEMENT – Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule. For information on submitting feed back go to https://www.federalregister.gov/documents/2020/09/01/2020-19289/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and NEWMARKER’S NEWSMAKERS – Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.
    続きを読む 一部表示
    55 分